Cite

HARVARD Citation

    Lancelot, M. et al. (2021). Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy. Transfusion. 61 (1), pp. 322-328. [Online]. 
  
Back to record